166 related articles for article (PubMed ID: 36348408)
1. NKD2 is correlated with the occurrence, progression and prognosis of thyroid carcinoma.
Gao Y; Wang Y; Guo R
Eur J Med Res; 2022 Nov; 27(1):235. PubMed ID: 36348408
[TBL] [Abstract][Full Text] [Related]
2. NKD2 Trigger NF-κB Signaling Pathway and Facilitates Thyroid Cancer Cell Proliferation.
Ke S; Pan Q; Wang C; Su Z; Li M; Liu X
Mol Biotechnol; 2023 Nov; 65(11):1846-1856. PubMed ID: 36820951
[TBL] [Abstract][Full Text] [Related]
3. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
[TBL] [Abstract][Full Text] [Related]
6. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
7. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of NKD2 in ovarian cancer.
Wei W; Zheng L; Gao Y; He M; Yang F
Jpn J Clin Oncol; 2021 Mar; 51(3):459-468. PubMed ID: 33324989
[TBL] [Abstract][Full Text] [Related]
9. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma.
Wang Y; Zhang Y; Li Y; Huang J
Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754
[TBL] [Abstract][Full Text] [Related]
10. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
Front Immunol; 2022; 13():964891. PubMed ID: 36059514
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Mitochondrial Transcription Termination Factor 3 in Thyroid Carcinoma.
Sun MT; Zhao HY; Ruan HJ; Yu LH; Guan ML; Fan JJ; Feng CZ; Lou YY
Genet Test Mol Biomarkers; 2023 Dec; 27(12):362-369. PubMed ID: 38156906
[No Abstract] [Full Text] [Related]
12. MicroRNA‑15b‑5p exerts its tumor repressive role via targeting GDI2: A novel insight into the pathogenesis of thyroid carcinoma.
Zou J; Qian J; Fu H; Yin F; Zhao W; Xu L
Mol Med Rep; 2020 Oct; 22(4):2723-2732. PubMed ID: 32945458
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid Cancer.
Li Z; Wang H; Deng X; Zhang J; Wang L; Tang W; You W; Nian W
Comb Chem High Throughput Screen; 2022; 25(13):2217-2227. PubMed ID: 35209814
[TBL] [Abstract][Full Text] [Related]
15. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
16. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
Front Genet; 2021; 12():744304. PubMed ID: 34976004
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Prognosis of Thyroid Cancer by Immune-related Genes.
Li J; Li Z; Zhao P
Am J Clin Oncol; 2024 Jan; 47(1):1-10. PubMed ID: 37779238
[TBL] [Abstract][Full Text] [Related]
18. TTN mutations predict a poor prognosis in patients with thyroid cancer.
Han X; Chen J; Wang J; Xu J; Liu Y
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis.
Li Z; Jia LI; Zhou HR; Zhang LU; Zhang M; Lv J; Deng ZY; Liu C
Cancer Genomics Proteomics; 2024; 21(1):102-117. PubMed ID: 38151291
[TBL] [Abstract][Full Text] [Related]
20. CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346.
Li X; Yang S; Zhao C; Yang J; Li C; Shen W; Hu H; Zhang W; Yang S
Endocr J; 2021 Aug; 68(8):1011-1025. PubMed ID: 34092745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
